Semaglutide
Showing 1 - 25 of 362
Scleroderma, Systemic, Fibrosis, Semaglutide Trial (Semaglutide Pen Injector)
Not yet recruiting
- Scleroderma, Systemic
- +2 more
- Semaglutide Pen Injector
- (no location specified)
Nov 20, 2023
Healthy Participants Trial in Cypress (Semaglutide J, Semaglutide C)
Recruiting
- Healthy Participants
- Semaglutide J
- Semaglutide C
-
Cypress, CaliforniaNovo Nordisk Investigational Site
Mar 28, 2023
Obesity Trial in Berlin (Semaglutide D Dose 1, Semaglutide D Dose 2, Semaglutide D Dose 3)
Completed
- Obesity
- Semaglutide D Dose 1
- +6 more
-
Berlin, GermanyNovo Nordisk Investigational Site
Dec 12, 2022
Healthy Volunteers (Diabetes, Type 2) Trial in Harrow (Semaglutide B, 1.34 mg/mL, Semaglutide D, 1.0 mg/mL)
Completed
- Healthy Volunteers (Diabetes Mellitus, Type 2)
- Semaglutide B, 1.34 mg/mL
- Semaglutide D, 1.0 mg/mL
-
Harrow, Middlesex, United KingdomNovo Nordisk Investigational Site
Jan 29, 2023
Semaglutide Use in Acute Pulmonary Embolism
Completed
- Pulmonary Embolism
- Semaglutide
-
London, United KingdomColm McCabe
Nov 3, 2023
Type 2 Diabetes Trial in Jinan (Semaglutide, Semaglutide Pen Injector [Ozempic])
Not yet recruiting
- Type 2 Diabetes
- Semaglutide
- Semaglutide Pen Injector [Ozempic]
-
Jinan, Shandong, ChinaShandong Provincial Hospital
Jul 11, 2023
Alcohol Use Disorder Trial in Aurora (Semaglutide 3 MG [Rybelsus], Semaglutide 7 MG [Rybelsus], Placebo)
Not yet recruiting
- Alcohol Use Disorder
- Semaglutide 3 MG [Rybelsus]
- +2 more
-
Aurora, ColoradoUniversity of Colorado Anschutz Medical Campus
Jun 6, 2023
Alcohol Use Disorder Trial in Tulsa (Semaglutide, Placebo)
Not yet recruiting
- Alcohol Use Disorder
- Semaglutide
- Placebo
-
Tulsa, OklahomaOSU Biomedical Imaging Center
Jun 5, 2023
Healthy Participants Trial in Neuss (Semaglutide)
Not yet recruiting
- Healthy Participants
- Semaglutide
-
Neuss, GermanyNovo Nordisk Investigational Site
Aug 10, 2023
Liver Transplant; Complications, Diabete Mellitus Trial (Semaglutide Pill)
Not yet recruiting
- Liver Transplant; Complications
- Diabete Mellitus
- Semaglutide Pill
- (no location specified)
Sep 23, 2023
Addiction, Alcohol Use Disorder Trial in Baltimore (Take Control, Semaglutide)
Recruiting
- Addiction
- Alcohol Use Disorder
- Take Control
- Semaglutide
-
Baltimore, MarylandNational Institute on Drug Abuse
Sep 2, 2023
Genetic Predisposition, Metabolic Diseases, Type 2 Diabetes Trial (Mixed Meal Tolerance Test (MMTT), Rybelsus)
Not yet recruiting
- Genetic Predisposition
- +2 more
- Mixed Meal Tolerance Test (MMTT)
- Rybelsus
- (no location specified)
Aug 18, 2023
Non-alcoholic Steatohepatitis Trial in Montreal (NNC0194-0499, Semaglutide, NNC0194-0499/Semaglutide A (40/3.20 mg/mL))
Not yet recruiting
- Non-alcoholic Steatohepatitis
- NNC0194-0499
- +3 more
-
Montreal, Quebec, CanadaNovo Nordisk Investigational Site
Mar 9, 2023
Diabetic Kidney Disease, Type 1 Diabetes Trial (Semaglutide, Placebo)
Not yet recruiting
- Diabetic Kidney Disease
- Type 1 Diabetes
- Semaglutide
- Placebo
- (no location specified)
Apr 18, 2023
Healthy Volunteers, Type 2 Diabetes Trial in Overland Park (Semaglutide D Dose 1, Semaglutide D Dose 2, Semaglutide D Dose 3)
Active, not recruiting
- Healthy Volunteers
- Type 2 Diabetes
- Semaglutide D Dose 1
- +5 more
-
Cypress, California
- +2 more
Dec 27, 2022
Gastric Content of Volunteers Fasting and Using
Completed
- Pneumonia, Aspiration
- Anesthesia
- semaglutide use
-
Sao Paulo, BrazilHospital Israelita Albert Einstein
Dec 1, 2023
Diabetes, Type 2 Trial in San Antonio (Oral semaglutide)
Recruiting
- Diabetes Mellitus, Type 2
- Oral semaglutide
-
San Antonio, TexasNovo Nordisk Investigational Site
Nov 18, 2022
Type 2 Diabetes, Osteopenia Trial in Odense (oral Semaglutide/Rybelsus, Placebo)
Not yet recruiting
- Type 2 Diabetes
- Osteopenia
- oral Semaglutide/Rybelsus
- Placebo
-
Odense, DenmarkOdense University Hospital
Sep 21, 2023
Diabetes, Type 1 Trial in Aurora (Semaglutide Pen Injector, Placebo)
Recruiting
- Diabetes Mellitus, Type 1
- Semaglutide Pen Injector
- Placebo
-
Aurora, ColoradoUniversity of Colorado Anschutz Medical Campus
Apr 20, 2023
Type 1 Diabetes Trial (Semaglutide weekly injection)
Not yet recruiting
- Type 1 Diabetes
- Semaglutide weekly injection
- (no location specified)
Sep 21, 2023
PCOS (Polycystic Ovary Syndrome), Semaglutide Trial in Peking (Metformin Hydrochloride 500 MG, Semaglutide, 1.34 mg/mL,
Not yet recruiting
- PCOS (Polycystic Ovary Syndrome)
- Semaglutide
- Metformin Hydrochloride 500 MG
- +4 more
-
Peking, Beijing, ChinaPekingUFH
Jan 18, 2023
Obesity, Interstitial Lung Disease, COPD Trial (Semaglutide Pen Injector)
Not yet recruiting
- Obesity
- +4 more
- Semaglutide Pen Injector
- (no location specified)
Feb 15, 2023
Cystic Fibrosis, Cystic Fibrosis-related Diabetes Trial in Minneapolis (Semaglutide)
Not yet recruiting
- Cystic Fibrosis
- Cystic Fibrosis-related Diabetes
- Semaglutide
-
Minneapolis, MinnesotaUniversity of Minnesota
Mar 15, 2023
PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries, Obese Trial (Semaglutide)
Not yet recruiting
- PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries
- Obese
- Semaglutide
- (no location specified)
Apr 6, 2023
Hyperglycemia, Renal Transplant Complication Primary Non-Function, Diabetes Trial (Semaglutide 14 MG [Rybelsus], Placebo)
Not yet recruiting
- Hyperglycemia
- +2 more
- Semaglutide 14 MG [Rybelsus]
- Placebo
- (no location specified)
Feb 1, 2023